BCIQ Profiles

Company Profile Report

WHO mapping out COVID-19 vaccines

WHO is creating a roadmap to develop COVID-19 vaccines

Scientists from biopharma companies, universities and regulatory agencies met at the WHO Feb. 11-12 to draw a roadmap for the development of vaccines to protect against COVID-19 amid a rapidly shifting terrain.

While knowledge about the disease is limited and changing daily, vaccine development is moving at an unprecedented pace. Priorities out of the WHO meeting include drafting a target product profile (TPP), designing a master protocol to test multiple vaccine candidates in parallel, and coordinating international work on animal models and standards, scientists who attended the meeting told BioCentury (see "Designing a Master Protocol for 2019-nCoV Outbreak").

The meeting, which considered a range of R&D issues in addition to vaccine development, was co-sponsored by WHO and the Global Research Collaboration for Infectious Disease Preparedness (GloPID-R). The vaccine working group was chaired by Philip Krause, deputy director of the Office of Vaccines Research and Review at FDA’s Center for Drug Evaluation

Read the full 1503 word article

How to gain access

Continue reading with a
two-week free trial.